期刊文献+

恶性肿瘤骨转移机制研究进展 被引量:5

Research progress on mechanisms of bone metastasis of malignant tumors
原文传递
导出
摘要 恶性肿瘤骨转移的发生包括肿瘤细胞的特性、骨骼微环境及两者之间的相互作用。溶骨和成骨是两种不同的病理类型,其发生机制各不相同。骨损害与肿瘤生长密切相关。 Bone metastasis is a common complication in patients with malignant carcinoma. This process involves interactions between metastatic cancer cells and bone microenvironment. The two common pathological types are osteolytic and osteoblastic metastasis. Damage to the bone is closely associated with tumor growth.
出处 《国际肿瘤学杂志》 CAS 2011年第1期67-69,共3页 Journal of International Oncology
关键词 肿瘤 肿瘤转移 转移机制 Neoplasms Neoplasm metastasis Mechanisms of metastasis
  • 相关文献

参考文献11

  • 1Kingsley LA, Fournier PG, Chirgwin JM, et al. Molecular biology of bone metastasis. Mol Cancer Ther, 2007, 6(10) :2609-2617.
  • 2Cotta CV, Konoplev S, Medeiros LJ,et al. Metastatic tumors in bone marrow: histopathology and advances in the biology of the tumor cells and bone marrow environment. Ann Diagn Pathol, 2006, 10 (3) : 169-192.
  • 3Gao D, Mittal V. The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression. Trends Mol Med, 2009, 15(8) :333-343.
  • 4Siclari VA, Guise TA, ChirgwinJM. Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases. Cancer Metastasis Rev, 2006, 25 (4) :621-633.
  • 5Mountzios G, Terpos E, Syrigos K, et al. Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid. Transl Res, 2010, 155 (5) :247-255.
  • 6Fili S, Karalaki M, Schaller B. Mechanism of bone metastasis: the role of osteoprotegerin and of the host-tissue microenvironment-related survival factors. Cancer Lett, 2009, 283 ( 1 ) : 10-19.
  • 7Tian E, Zhan F, Walker R, et al. The role of the Wnt-signaling antagonist DKKI in the development of osteolytie lesions in multiple myeloma. N Engl J Med, 2003, 349(26) :2483-2494.
  • 8Bagnato A, Rosano L. The endothelin axis in cancer, Int J Biochem Cell Biol, 2008, 40(8) :1443-1451.
  • 9Hall CL, Kang S, MacDougald OA, et al. Role of Wnts in prostate cancer bone metastases. J Cell Biochem, 2006, 97 (4) :661-672.
  • 10Yi B, Williams PJ, Niewolna M, et al. Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer. Cancer Res, 2002, 62(3 ) :917-923.

同被引文献30

  • 1Soonthornthum T, Suraseraneewong V, Kengsakol K, et al.Thrombocytosis in advanced epithelial ovarian cancer[J].J Med Assoc Thai, 2007, 90 (8) : 1495-1500.
  • 2Sasaki K, Kawai K, Tsuno N H, et al.Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer[J].World J Surg, 2012, 36 (1) : 192-200.
  • 3Iwasaki A, Hamanaka W, Harnada T, et al.Significance of platelet counts in patients who underwent surgical treatment for lung metastasis[J].International surgery, 2007, 92 (2) : 103-109.
  • 4Pedersen L M, Milman N.Prognostic significance of thrombocytosis in patients with primary lung cancer[J].Eur Respir J, 1996, 9 (9) :1826-1830.
  • 5Lehmann J, Retz M, Nurnberg N, et a|.The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinoma[J].Caneer, 2004, 101 (7) : 1552- 1562.
  • 6Ikeda M, Furukawa H, Imamura H, et al.Poor prognosis associated with thrombocytosis inpatients with gastric cancer[J].Annals of Surgical Oncology, 2002, 9 (3) : 287-291.
  • 7SuzuKi K, Aiura K, Kitagou M, et al.Platelets counts closely correlate with the disease-free survival interval of pancreatic cancer patients[J].Hepato-gastroenterology, 2004, 51 (57) : 847-853.
  • 8Shimada H, Oohira G, Okazumi S, et al.Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma[J].Journal of the American College of Surgeons, 2004, 198 (5) : 737-741.
  • 9Tomita M, Shimizu T, Ham M, et al.Prognostic impact of thrombocytosis in respectable non-small cell lung cancer [J]. Interactive cardiovascular and thoracic surgery, 2008, 7 (4) : 613- 615.
  • 10Khorana A A, Kuderer N M, Culakova E, et al.Development and validation of a predictive model for chemotherapy associated thrombosis[J].Blood, 2008, 111 (10) : 4902-4907.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部